Liu Hongbing, deputy governor of Guangdong province, met with Lance Little, global vice president of Roche Diagnostics, and his delegation in Guangzhou on March 19.

Roche Diagnostics, a leading Swiss pharmaceutical company, specializes in producing diagnostic products for cancer, cardiac health, infectious diseases, and diabetes management.

Liu said that Guangdong's biopharmaceutical industry has formed a strong cluster supported by an innovative ecosystem, bolstered by its expansive market, comprehensive industrial system, targeted policy support, and a strategic geographical location.

He said that the cooperation between Guangdong and Roche Diagnostics has a solid foundation and strong potential.

Liu expressed hope that Roche Diagnostics will utilize the policy benefits of the Guangdong-Hong Kong-Macao Greater Bay Area to expand its business in Guangdong.

He added that Guangdong will strive to build a first-class business environment that is market-oriented, rule-of-law-based, and internationalized, as well as provide efficient services for foreign-funded enterprises.

Little introduced the company's development situation and expressed a willingness to collaborate with Guangdong partners to develop digital products.

He also underscored the significance of deepening cooperation in medical devices and liver disease prevention and treatment to achieve mutual benefits.